Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03817190 · TERMINATED
Trial details
- NCT number
- NCT03817190
- Sponsor
- DS Biopharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2020-09-03
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.